Well being Information Roundup: FDA Quickly to Approve Pfizer’s COVID Booster Shot for Youthful Kids – NYT; Valneva shares plummet after COVID vaccine take care of EU falls aside and extra

Below is a summary of the latest health news.

Shanghai targets COVID lockdown exit in June as Chinese economy slumps

Shanghai on Monday laid out plans for ending a painful COVID-19 lockdown that lasted more than six weeks and severely hurting China’s economy and for returning to more normal life from June 1. In the clearest timeline yet, Deputy Mayor Zong Ming said Shanghai will gradually reopen, with movement restrictions largely remaining in place until May 21 to prevent a resurgence in infections ahead of an easing.

The coronavirus can be linked to cases of severe hepatitis in children

The following is a summary of some recent studies on COVID-19. This includes research results that warrant further studies to confirm the results and that have yet to be certified through peer review. SARS-CoV-2 could be the cause of mysterious hepatitis in children

FDA soon approves Pfizer’s COVID booster shot for younger children – NYT

U.S. health officials are expected to approve a booster shot of Pfizer/BioNTech’s COVID-19 vaccine for children ages 5 to 11 as early as Tuesday, the New York Times reported Monday, citing people familiar with the matter Persons. The companies filed an application for approval with the U.S. Food and Drug Administration last month.

Abbott and FDA reach agreement to reopen infant formula plant in Michigan

Abbott Laboratories announced Monday that it has reached an agreement with the U.S. Food and Drug Administration regarding the necessary steps to resume production and maintain its baby formula facility in Sturgis, Michigan.

Explainer – What happened to the Abbott baby formula that made a shortage worse in the US?

Abbott Laboratories, the largest US supplier of powdered infant formulas, including Similac, initiated a recall earlier this year and closed its Sturgis, Michigan manufacturing facility after reports of serious bacterial infections in four infants. The recall and closure have exacerbated a baby formula shortage at several manufacturers that began with supply chain problems from the pandemic.

US sees baby food imports amid nationwide shortage

U.S. health officials will announce measures against baby food imports as early as Monday to address a nationwide shortage that has caused parents to scramble to feed their babies, the Food and Drug Administration chief said. FDA Commissioner Robert Califf gave no details, but President Joe Biden said last week he was working to bring in more formulas from other countries.

Valneva shares plummet after COVID vaccine deal with EU falls apart

Valneva shed nearly a fifth of its value on Monday after the French drugmaker said its COVID-19 vaccine deal with the European Commission is likely to be scrapped and it may have to reconsider its financial guidance. Valneva said the European Commission (EC) has informed the company of its intention to terminate a pre-purchase agreement for its COVID vaccine.

In the absence of vaccines, North Korea is fighting COVID with antibiotics and home remedies

Standing in bright red hazmat suits, five North Korean health workers stride toward an ambulance to fight a COVID-19 outbreak the country is treating — for lack of a vaccine — with antibiotics and home remedies. The isolated state is one of only two countries yet to launch a vaccination campaign and had insisted it was COVID-free until last week.

FDA refuses to approve a common antidepressant as a COVID treatment

The U.S. Food and Drug Administration has decided not to approve the antidepressant fluvoxamine to treat COVID-19 because data did not show the drug to be an effective therapeutic to fight the virus. “Based on a review of the available scientific evidence, the FDA has determined that there is insufficient data to conclude that fluvoxamine may be effective in treating unhospitalized patients with COVID-19 to slow the progression of serious illness and/or prevent hospitalization,” the agency said in a document released Monday https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/EUA%20110%20Fluvoxamine%20Decisional%20Memo_Redacted.pdf.

Starbucks is adding travel insurance for abortions to US healthcare coverage

Starbucks Corp will reimburse U.S. employees if they travel more than 100 miles from their home for an abortion, according to a memo sent to employees Monday. The global coffee chain joins Amazon.com Inc, Microsoft Corp and a small but growing list of other companies to offer the benefits as some US states impose stricter restrictions on abortion.

(With agency contributions.)

Comments are closed.